Financial Snapshot

Revenue
$88.18M
TTM
Gross Margin
62.55%
TTM
Net Earnings
-$24.17M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
323.45%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$114.5M
Q3 2024
Cash
Q3 2024
P/E
-4.115
Nov 29, 2024 EST
Free Cash Flow
-$1.120M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $71.52M $62.45M $61.29M $43.31M $24.60M $21.21M $12.13M $7.750M $7.220M $6.500M $4.680M $1.990M $1.110M
YoY Change 14.53% 1.89% 41.52% 76.06% 15.98% 74.86% 56.52% 7.34% 11.08% 38.89% 135.18% 79.28%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $71.52M $62.45M $61.29M $43.31M $24.60M $21.21M $12.13M $7.750M $7.220M $6.500M $4.680M $1.990M $1.110M
Cost Of Revenue $28.62M $23.48M $25.65M $19.21M $9.160M $9.000M $6.170M $3.410M $3.620M $3.220M $1.860M $120.0K
Gross Profit $42.90M $38.97M $35.64M $24.11M $15.44M $12.21M $5.950M $4.340M $3.600M $3.280M $2.820M $1.870M
Gross Profit Margin 59.98% 62.4% 58.14% 55.67% 62.76% 57.57% 49.05% 56.0% 49.86% 50.46% 60.26% 93.97%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Selling, General & Admin $58.02M $33.49M $33.19M $23.08M $17.85M $10.18M $6.620M $5.110M $3.240M $3.340M $2.680M $2.140M $2.420M
YoY Change 73.25% 0.9% 43.81% 29.3% 75.34% 53.78% 29.55% 57.72% -2.99% 24.63% 25.23% -11.57%
% of Gross Profit 135.25% 85.94% 93.13% 95.73% 115.61% 83.37% 111.26% 117.74% 90.0% 101.83% 95.04% 114.44%
Research & Development $1.080M $1.420M $1.010M $400.0K $290.0K $190.0K $80.00K
YoY Change 40.59% 152.5% 37.93% 52.63% 137.5%
% of Gross Profit 4.48% 11.63% 16.97% 9.22% 8.06% 5.79% 2.84%
Depreciation & Amortization $2.402M $2.022M $1.965M $1.970M $1.180M $320.0K $320.0K $240.0K $330.0K $260.0K $190.0K $190.0K $150.0K
YoY Change 18.77% 2.88% -0.24% 66.95% 268.75% 0.0% 33.33% -27.27% 26.92% 36.84% 0.0% 26.67%
% of Gross Profit 5.6% 5.19% 5.51% 8.17% 7.64% 2.62% 5.38% 5.53% 9.17% 7.93% 6.74% 10.16%
Operating Expenses $60.42M $51.26M $35.28M $26.24M $19.13M $12.03M $8.090M $5.870M $4.200M $3.910M $3.090M $2.320M $2.560M
YoY Change 17.88% 45.3% 34.44% 37.17% 59.02% 48.7% 37.82% 39.76% 7.42% 26.54% 33.19% -9.38%
Operating Profit -$17.52M -$12.29M $361.1K -$2.130M -$3.690M $180.0K -$2.140M -$1.530M -$600.0K -$630.0K -$270.0K -$450.0K
YoY Change 42.56% -3503.69% -116.95% -42.28% -2150.0% -108.41% 39.87% 155.0% -4.76% 133.33% -40.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Interest Expense $737.9K $852.3K $16.98K -$70.00K -$350.0K $50.00K $30.00K $40.00K $0.00 $0.00 $0.00 $0.00 -$960.0K
YoY Change -13.42% 4919.43% -124.26% -80.0% -800.0% 66.67% -25.0% -100.0%
% of Operating Profit 4.7% 27.78%
Other Income/Expense, Net $500.0K $852.3K $0.00 -$140.0K -$640.0K
YoY Change -41.34% -100.0% -78.13%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Pretax Income -$25.16M -$11.44M $378.1K -$2.210M -$4.040M $230.0K -$2.100M -$1.540M -$600.0K -$1.030M -$270.0K -$450.0K -$2.120M
YoY Change 119.99% -3125.4% -117.11% -45.3% -1856.52% -110.95% 36.36% 156.67% -41.75% 281.48% -40.0% -78.77%
Income Tax -$7.598M -$900.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$17.57M -$11.44M $378.1K -$2.210M -$3.140M $230.0K -$2.100M -$1.540M -$600.0K -$1.030M -$270.0K -$450.0K -$2.120M
YoY Change 53.57% -3125.4% -117.11% -29.62% -1465.22% -110.95% 36.36% 156.67% -41.75% 281.48% -40.0% -78.77%
Net Earnings / Revenue -24.56% -18.32% 0.62% -5.1% -12.76% 1.08% -17.31% -19.87% -8.31% -15.85% -5.77% -22.61% -190.99%
Basic Earnings Per Share -$1.03 -$0.64 $0.02
Diluted Earnings Per Share -$1.03 -$0.64 $21.37K -$149.0K -$234.5K $19.39K -$213.8K -$155.6K -$73.26K -$138.1K -$56.25K -$94.94K -$456.9K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Cash & Short-Term Investments $13.85M $74.14M $84.68M $10.52M $18.85M $8.910M $5.120M $7.030M $8.210M $3.450M $1.120M $280.0K $960.0K
YoY Change -81.32% -12.45% 704.96% -44.19% 111.56% 74.02% -27.17% -14.37% 137.97% 208.04% 300.0% -70.83%
Cash & Equivalents $13.85M $18.21M $84.68M $10.52M $18.85M $8.910M $5.120M $7.030M $8.210M $3.450M $1.120M $280.0K $960.0K
Short-Term Investments $0.00 $55.93M
Other Short-Term Assets $3.189M $2.281M $5.631M $4.460M $870.0K $360.0K $260.0K $80.00K $70.00K $30.00K $10.00K $70.00K $120.0K
YoY Change 39.84% -59.49% 26.25% 412.64% 141.67% 38.46% 225.0% 14.29% 133.33% 200.0% -85.71% -41.67%
Inventory
Prepaid Expenses
Receivables $36.25M $22.16M $24.80M $17.89M $7.420M $6.460M $3.430M $3.060M $2.850M $2.100M $1.510M $620.0K $470.0K
Other Receivables $1.036M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $54.33M $98.58M $115.1M $32.86M $27.14M $15.73M $8.810M $10.18M $11.13M $5.580M $2.640M $970.0K $1.550M
YoY Change -44.88% -14.37% 250.31% 21.08% 72.54% 78.55% -13.46% -8.54% 99.46% 111.36% 172.16% -37.42%
Property, Plant & Equipment $722.3K $372.8K $472.6K $590.0K $740.0K $150.0K $170.0K $170.0K $10.00K $10.00K $20.00K $20.00K $20.00K
YoY Change 93.77% -21.13% -19.89% -20.27% 393.33% -11.76% 0.0% 1600.0% 0.0% -50.0% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $568.1K $5.050K $12.86K $10.00K $80.00K $240.0K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K
YoY Change 11148.51% -60.73% 28.6% -87.5% -66.67% 2300.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Long-Term Assets $129.0M $36.07M $25.87M $27.47M $29.50M $9.320M $950.0K $1.300M $1.180M $1.450M $1.310M $1.210M $1.340M
YoY Change 257.71% 39.43% -5.82% -6.88% 216.52% 881.05% -26.92% 10.17% -18.62% 10.69% 8.26% -9.7%
Total Assets $183.4M $134.7M $141.0M $60.33M $56.64M $25.05M $9.760M $11.48M $12.31M $7.030M $3.950M $2.180M $2.890M
YoY Change
Accounts Payable $2.227M $1.550M $606.8K $620.0K $490.0K $410.0K $460.0K $370.0K $780.0K $770.0K $760.0K $620.0K $910.0K
YoY Change 43.69% 155.43% -2.13% 26.53% 19.51% -10.87% 24.32% -52.56% 1.3% 1.32% 22.58% -31.87%
Accrued Expenses $7.976M $2.691M $2.994M $2.540M $1.920M $1.300M $950.0K $290.0K $10.00K $30.00K $10.00K $10.00K $70.00K
YoY Change 196.39% -10.11% 17.87% 32.29% 47.69% 36.84% 227.59% 2800.0% -66.67% 200.0% 0.0% -85.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M
YoY Change
Total Short-Term Liabilities $17.88M $8.396M $9.369M $10.03M $6.110M $4.230M $3.540M $3.670M $3.370M $2.420M $2.280M $770.0K $1.300M
YoY Change 112.98% -10.38% -6.59% 64.16% 44.44% 19.49% -3.54% 8.9% 39.26% 6.14% 196.1% -40.77%
Long-Term Debt $34.23M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $371.4K $144.5K $236.7K $330.0K $5.670M $2.370M
YoY Change 157.0% -38.95% -28.26% -94.18% 139.24%
Total Long-Term Liabilities $34.60M $144.5K $236.7K $330.0K $5.670M $2.370M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 23841.17% -38.95% -28.26% -94.18% 139.24%
Total Liabilities $56.82M $8.540M $9.605M $10.35M $11.78M $6.600M $3.540M $3.670M $3.370M $2.420M $2.280M $770.0K $1.300M
YoY Change 565.32% -11.09% -7.19% -12.14% 78.48% 86.44% -3.54% 8.9% 39.26% 6.14% 196.1% -40.77%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Basic Shares Outstanding 17.12M shares 17.78M shares 17.23M shares
Diluted Shares Outstanding 17.12M shares 17.78M shares 17.69M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $99.473 Million

About OptimizeRx Corp

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 116 full-time employees. The company went IPO on 2005-05-18. The company offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

Industry: Services-Business Services, NEC Peers: Babylon Holdings Ltd TruBridge, Inc. Sharecare, Inc. Health Catalyst, Inc. HEALTHSTREAM INC Pear Therapeutics, Inc. Tabula Rasa HealthCare, Inc. Akili, Inc.